The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study

Journal of the American Society of Hypertension

Volumn 10, Issue 11, 2016, Pages 857-864.e2

  Haley, William E ^a   Gilbert, Olivia N ^b   Riley, Robert F ^c   Newman, Jill C ^d   Roumie, Christianne L ^e   Whittle, Jeffrey ^f   Kronish, Ian M ^g   Tamariz, Leonardo ^h   Wiggers, Alan ⁱ   Morisky, Donald E ^j   Conroy, Molly B ^k   Kovalik, Eugene ^l   Kressin, Nancy R ^m   Muntner, Paul ⁿ   Goff, David C ^o  

^a MAYO CLINIC   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g Department of Medicine   (United States)

^h UNIVERSITY OF MIAMI HEALTH SYSTEM   (United States)

ⁱ UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^o Food Science and Human Nutrition   (United States)

more..

Author keywords

Clinical trial; hypertension; MMAS 8

Indexed keywords

ANTIHYPERTENSIVE AGENT;

8 ITEM MORISKY MEDICATION ADHERENCE SCALE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CROSS-SECTIONAL STUDY; DRUG EFFICACY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; AGE; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECTS; HYPERTENSION; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SYSTOLE;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; SELF REPORT; SEX FACTORS; SYSTOLE;

EID: 84994435925     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.08.009     Document Type: Article

References (25)

1. 1 Haynes, R.B., McDonald, H.P., Garg, A.X., Helping patients follow prescribed treatment: clinical applications. JAMA 288:22 (2002), 2880–2883.
2. 2 DiMatteo, M.R., Giordani, P.J., Lepper, H.S., Croghan, T.W., Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40:9 (2002), 794–811.
3. 3 Holland, N., Segraves, D., Nnadi, V.O., Belletti, D.A., Wogen, J., Arcona, S., Identifying barriers to hypertension care: implications for quality improvement initiatives. Dis Manag 11:2 (2008), 71–77.
4. 4 McDermott, M.M., Schmitt, B., Wallner, E., Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 157:17 (1997), 1921–1929.
5. 5 Mendis, S., Salas, M., Adherence to long-term therapies: evidence for action. Sabate, E., (eds.) Hypertension. Chapter XIII, 2003, World Health Organization, Geneva, Switzerland, 107–114.
6. 6 Gosmanova, E.O., Kovesdy, C.P., Adherence to antihypertensive medications: is prescribing the right pill enough?. Nephrol Dial Transplant 30:10 (2015), 1649–1656.
7. 7 Hsu, K.L., Fink, J.C., Ginsberg, J.S., Yoffe, M., Zhan, M., Fink, W., et al. Self reported medication adherence and adverse patient safety events in CKD. Am J Kidney Dis 66:4 (2015), 621–629.
8. 8 Krousel-Wood, M., Thomas, S., Muntner, P., Morisky, D., Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19:4 (2004), 357–362.
9. 9 Morisky, D.E., Ang, A., Krousel-Wood, M., Ward, H.J., Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:5 (2008), 348–354.
10. 10 Ambrosius, W.T., Sink, K.M., Foy, C.G., Berlowitz, D.R., Cheung, A.K., Cushman, W.C., et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 11:5 (2014), 532–546.
11. 11 Weber, M.A., Schiffrin, E.L., White, W.B., Mann, S., Lindholm, L.H., Kenerson, J.G., et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 16:1 (2014), 14–26.
12. 12 Whitworth, J.A., Chalmers, J., World Health Organisation-International Society of Hypertension (WHO/ISH) hypertension guidelines. Clin Exp Hypertens 26:7-8 (2004), 747–752.
13. 13 James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
14. 14 Taylor, A.A., Shoheiber, O., Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 9:6 (2003), 324–332.
15. 15 Jung, O., Gechter, J.L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 31:4 (2013), 766–774.
16. 16 Ceral, J., Habrdova, V., Vorisek, V., Bima, M., Pelouch, R., Solar, M., Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res 34:1 (2011), 87–90.
17. 17 De Geest, S., Ruppar, T., Berben, L., Schönfeld, S., Hill, M.N., Medication non-adherence as a critical factor in the management of presumed resistant hypertension: a narrative review. EuroIntervention 9:9 (2014), 1102–1109.
18. 18 De Geest, S., Sabaté, E., Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs, 2(4), 2003, 323.
19. 19 Osterberg, L., Blaschke, T., Adherence to medication. N Engl J Med 353:5 (2005), 487–497.
20. 20 Christensen, D.B., Williams, B., Goldberg, H.I., Martin, D.P., Engelberg, R., LoGerfo, J.P., Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 35:11 (1997), 1164–1170.
21. 21 Pérez-Escamilla, B., Franco-Trigo, L., Moullin, J.C., Martínez-Martínez, F., García-Corpas, J.P., Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence 9 (2015), 569–578.
22. 22 Morisky, D.E., DiMatteo, M.R., Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 64:3 (2011), 255–257 discussion 258–63.
23. 23 AlGhurair, S.A., Hughes, C.A., Simpson, S.H., Guirguis, L.M., A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens (Greenwich) 14:12 (2012), 877–886.
24. 24 Krousel-Wood, M.A., Islam, T., Webber, L.S., Re, R.S., Morisky, D.E., Muntner, P., New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15:1 (2009), 59–66.
25. 25 Heo, M., Kim, N., Faith, M.S., Statistical power as a function of Cronbach alpha of instrument questionnaire items. BMC Med Res Methodol, 15, 2015, 86.